Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
- 15 January 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (2), 510-517
- https://doi.org/10.1158/0008-5472.can-08-0858
Abstract
The export protein CRM1 is required for the nuclear export of a wide variety of cancer-related “cargo” proteins including p53, c-Abl, and FOXO-3A. Leptomycin B (LMB) is a highly specific inhibitor of CRM1 with significant in vitro potency but limited in vivo efficacy due to toxicity. We now report a series of semisynthetic LMB derivatives showing substantially improved therapeutic windows. Exposure of cancer cells to these compounds leads to a rapid and prolonged block of nuclear export and apoptosis. In contrast to what is observed in cancer cells, these agents induce cell cycle arrest, but not apoptosis, in normal lung fibroblasts. These new nuclear export inhibitors (NEI) maintain the high potency of LMB, are up to 16-fold better tolerated than LMB in vivo, and show significant efficacy in multiple mouse xenograft models. These NEIs show the potential of CRM1 inhibitors as novel and potent anticancer agents. [Cancer Res 2009;69(2):510–7]Other Versions
This publication has 35 references indexed in Scilit:
- PTEN regulates p300-dependent hypoxia-inducible factor 1 transcriptional activity through Forkhead transcription factor 3a (FOXO3a)Proceedings of the National Academy of Sciences of the United States of America, 2008
- Selective induction of apoptosis by leptomycin B in keratinocytes expressing HPV oncogenesInternational Journal of Cancer, 2007
- Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancerExperimental Gerontology, 2006
- BCR-ABL nuclear entrapment kills human CML cells: ex vivo study on 35 patients with the combination of imatinib mesylate and leptomycin BBlood, 2006
- Leptomycin B stabilizes and activates p53 in primary prostatic epithelial cells and induces apoptosis in the LNCaP cell lineThe Prostate, 2003
- Effects on normal fibroblasts and neuroblastoma cells of the activation of the p53 response by the nuclear export inhibitor leptomycin BOncogene, 1999
- An Inhibitor of Nuclear Export Activates the p53 Response and Induces the Localization of HDM2 and p53 to U1A-Positive Nuclear Bodies Associated with the PODsExperimental Cell Research, 1999
- Effect of Bcr sequences on the cellular function of the Bcr-Abl oncoproteinOncogene, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor proteinCell, 1993